CAREDX, INC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.01 USD | -3.77% |
|
-18.38% | +8.42% |
| May. 30 | CareDx, Inc Announces New Data to Be Presented At the 2024 American Transplant Congress | CI |
| May. 17 | Craig-Hallum Adjusts Price Target on CareDx to $22 From $15, Maintains Buy Rating | MT |
Chart calendar CareDx, Inc
fb2824e0.B_GF-iZtxznfY1grsTpBykvvFsqFdcEaT072QNn92lo.NoX8zRA4gW_nMRdJwnUP-gWMRf3WJYR1I3efNoy5qgo0wMCgQSmMf-kbHQ~128df1a1637df4a9155d76054c81c692
Upcoming events on CareDx, Inc
Past events on CareDx, Inc
| Today | American Transplant Congress - Abstract No: 363 |
| Today | American Transplant Congress - Abstract No: A174 |
| Today | American Transplant Congress - Abstract No: A184 |
| Today | American Transplant Congress - Abstract No: C062 |
| Today | American Transplant Congress - Abstract No: D148 |
| 2024-05-09 04:30 pm | Q1 2024 Earnings Call |
| 2024-05-09 04:05 pm | Q1 2024 Earnings Release |
| 2024-03-06 09:50 am | Raymond James Institutional Investors Conference |
| 2024-02-28 04:30 pm | Q4 2023 Earnings Call |
| 2024-02-28 04:05 pm | Q4 2023 Earnings Release |
| 2024-01-10 | American Society of Transplant Surgeons Winter Symposium |
| 2023-11-08 04:30 pm | Q3 2023 Earnings Call |
| 2023-11-08 04:05 pm | Q3 2023 Earnings Release |
| 2023-09-27 10:20 am | Cantor Global Healthcare Conference |
| 2023-09-16 | European Society for Organ Transplantation Congress |
| 2023-09-12 03:30 pm | H.C. Wainwright Global Investment Conference |
| 2023-08-26 | Management Expert Exchange in Transplantation Conference |
| 2023-08-08 04:30 pm | Q2 2023 Earnings Call |
| 2023-08-08 04:05 pm | Q2 2023 Earnings Release |
| 2023-06-15 01:00 pm | Annual General Meeting |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 127 127 -0.04% | 192 192 0.06% | 296 295 0.39% | 322 321 0.14% | 280 278 0.7% | 278 |
|
EBITDA Million USD | Released Forecast Spread | 4,16 4,39 -5.06% | 7,96 -8,10 198.33% | 17,8 25,1 -29.1% | -17,5 -13,4 -30.78% | -38,0 -39,2 3.21% | -18,9 |
|
EBIT Million USD | Released Forecast Spread | -24,5 -25,8 4.97% | -22,5 -27,1 16.83% | -29,7 -23,9 -24.5% | -77,2 -76,5 -0.96% | -203 -109 -86.24% | -84,7 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -23,9 -25,7 6.78% | -19,8 -23,5 15.94% | -32,1 -24,5 -30.73% | -76,2 -76,5 0.29% | -190 -98,4 -93.32% | -74,1 |
|
Net income Million USD | Released Forecast Spread | -22,0 -23,8 7.73% | -18,7 -22,0 15.01% | -30,7 -23,9 -28.43% | -76,6 -76,7 0.06% | -190 -98,4 -93.44% | -74,0 |
|
EPS USD | Released Forecast Spread | -0,52 -0,56 7.56% | -0,40 -0,48 15.97% | -0,59 -0,45 -31.11% | -1,44 -1,44 0% | -3,54 -1,83 -93.44% | -1,43 |
| Announcement Date | 27/02/20 | 24/02/21 | 24/02/22 | 27/02/23 | 28/02/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 79,4 79,3 0.2% | 80,6 81,9 -1.49% | 79,4 82,6 -3.95% | 82,4 82,0 0.47% | 77,3 80,8 -4.41% | 70,3 61,8 13.81% | 67,2 53,1 26.43% | 65,6 64,1 2.35% | 72,0 63,1 14.12% | 67,8 | 69,2 | 69,7 | 73,3 | 72,3 |
|
EBITDA Million USD | Released Forecast Spread | -5,65 -3,38 -67.05% | -5,73 -6,28 8.73% | -2,48 -6,06 59.16% | -3,68 -1,54 -138.69% | -6,42 -2,53 -153.31% | -10,4 -21,1 50.99% | -10,9 -20,1 45.52% | -10,3 -13,8 25.56% | -1,86 -12,0 84.59% | -7,81 | -5,24 | -4,51 | -1,25 | -1,40 |
|
EBIT Million USD | Released Forecast Spread | -19,1 -15,5 -23.07% | -21,7 -18,7 -16.35% | -17,3 -20,3 14.49% | -19,1 -18,4 -3.98% | -24,3 -17,8 -36.68% | -27,6 -29,9 7.74% | -28,8 -35,8 19.57% | -123 -28,5 -330.66% | -19,3 -27,9 30.71% | -23,4 | -21,2 | -20,7 | -19,6 | -17,9 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -19,7 -6,49 -202.81% | -21,7 -18,6 -16.68% | -16,7 -20,2 17.41% | -18,2 -18,4 1.16% | -23,6 -17,2 -37.74% | -25,0 -28,6 12.61% | -23,6 -34,3 31.39% | -118 -26,1 -350.99% | -16,7 -24,4 31.35% | -20,7 | -18,5 | -18,2 | -17,4 | -15,8 |
|
Net income Million USD | Released Forecast Spread | -19,6 -6,28 -213.02% | -21,7 -18,1 -19.83% | -16,9 -20,9 18.87% | -18,3 -18,4 0.25% | -23,7 -17,2 -38.02% | -25,0 -29,3 14.81% | -23,5 -34,4 31.72% | -118 -26,2 -351.13% | -16,7 -24,7 32.5% | -20,7 | -18,5 | -18,2 | -17,4 | -15,8 |
|
EPS USD | Released Forecast Spread | -0,37 -0,12 -208.33% | -0,41 -0,34 -20.59% | -0,32 -0,39 18.37% | -0,34 -0,34 0.73% | -0,44 -0,32 -36.65% | -0,46 -0,54 15.44% | -0,43 -0,64 32.39% | -2,21 -0,49 -352.87% | -0,32 -0,47 31.18% | -0,40 | -0,36 | -0,35 | -0,34 | -0,31 |
| Announcement Date | 05/05/22 | 04/08/22 | 03/11/22 | 27/02/23 | 10/05/23 | 08/08/23 | 08/11/23 | 28/02/24 | 09/05/24 | - | - | - | - | - |
More events
Past sector events for CareDx, Inc
| 2024-05-09 | SEEGENE, INC.: Q1 2024 Earnings Release |
| 2024-05-09 04:05 pm | GUARDANT HEALTH, INC.: Q1 2024 Earnings Release |
| 2024-05-09 04:01 pm | IOVANCE BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-08 04:05 pm | MARAVAI LIFESCIENCES HOLDINGS, INC.: Q1 2024 Earnings Release |
| 2024-05-08 04:05 pm | EXACT SCIENCES CORPORATION: Q1 2024 Earnings Release |
| 2024-05-07 04:05 pm | VERACYTE, INC.: Q1 2024 Earnings Release |
| 2024-04-26 | BGI GENOMICS CO., LTD.: Q1 2024 Earnings Release |
| 2024-04-12 | BGI GENOMICS CO., LTD.: Q4 2023 Earnings Release |
| 2024-02-28 04:05 pm | CAREDX, INC: Q4 2023 Earnings Release |
| 2024-02-28 04:01 pm | IOVANCE BIOTHERAPEUTICS, INC.: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- CDNA Stock
- Calendar CareDx, Inc
